Press releaseGlobe Newswire
First Advantage
FA · NASDAQ
$19.56+$0.61 (+3.22%)TodayMarket closed ·
Prev close $18.95
About FA
- Employees
- 9,500
- Headquarters
- Atlanta, Georgia
- Listed
- Jun 23, 2021
- Sector
- Industrials
- Industry
- Professional Services
- Website
- fadv.com
FA key statistics
- Market cap
- 3.25B
- Price-earnings ratio
- 135.36
- Dividend yield
- 0.00%
- Average volume
- 1.80M
- Volume
- 779.55K
- Open price
- $19.29
- High today
- $19.85
- Low today
- $19.29
- 52 Week high
- $25.15
- 52 Week low
- $8.82
First Advantage (FA) at a glance
First Advantage (FA) last traded at $19.56, with a market cap of 3.25B, a price-to-earnings ratio of 135.36 and a dividend yield of 0.00%.
Today the stock has traded between $19.29 and $19.85. The current price is 1.4% above the day's low and 1.5% below its high.
Volume so far is 779.55K shares, below the average of 1.80M shares a day.
Over the past year First Advantage has ranged from $8.82 to $25.15, and now sits 66% of the way up that range.
First Advantage met or beat analyst EPS estimates in 7 of the last 8 quarters. In Q2 FY26 it reported $0.35 per share against an estimate of $0.2936.
The average analyst price target is $26.02, 33.0% above the current price, from 5 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
60%of 5 analyst ratings say Buy
- Buy60.0%
- Hold40.0%
- Sell0.0%
Price target · 12 analystsAvg $26.02
- Low
- $22.22
- Now
- $19.56
- High
- $31.50
FA earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 7 of the last 8 quarters, by 13.1% on average.
- Q3 FY24: reported $0.26 per share against an estimate of $0.2594
- Q4 FY24: reported $0.18 per share against an estimate of $0.2321
- Q1 FY25: reported $0.17 per share against an estimate of $0.1354
- Q2 FY25: reported $0.27 per share against an estimate of $0.2443
- Q3 FY25: reported $0.30 per share against an estimate of $0.2886
- Q4 FY25: reported $0.30 per share against an estimate of $0.2708
- Q1 FY26: reported $0.26 per share against an estimate of $0.2138
- Q2 FY26: reported $0.35 per share against an estimate of $0.2936
FA news
- Press releaseGlobe Newswire
First Advantage to Release Third Quarter 2026 Financial Results and Hold Investor Conference Call on November 5, 2026
- Press releasePRNewswire
MDpanel Appoints Manish Nariwal Chief Operating Officer and Jim Andrews Chief Client Officer
- Press releaseGlobe Newswire
First Advantage to Participate in Upcoming Investor Conferences
- Press releaseGlobe Newswire
First Advantage Reports Second Quarter 2026 Results
- Press releaseGlobe Newswire
First Advantage to Release Second Quarter 2026 Financial Results and Hold Investor Conference Call on August 6, 2026
- Press releaseGlobe Newswire
A Weight-Loss Revolution Is Reshaping Bodies. This Preclinical Biotech Wants to Build What Comes Next
- Press releasePRNewswire
First Advantage Set to Join S&P SmallCap 600
Similar companies
Companies in the same industry as First Advantage
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- FRTTFort Technology$0.7121+32.63%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.